Volume 39, Issue 2 pp. 138-142
Original Study

Use of a pneumatic compression system (FEMOSTOPB®) as a treatment option for femoral artery pseudoaneurysms after percutaneous cardiac procedures

George Dangas MD

Corresponding Author

George Dangas MD

Cardiovascular Institute, Mount Sinai Medical Center, New York City

Cardiovascular Institute (Box 1030), Mount Sinai Medical Center, One Gustave L. Levy Place, New York, NY 10029Search for more papers by this author
Roxana Mehran MD

Roxana Mehran MD

Cardiovascular Institute, Mount Sinai Medical Center, New York City

Search for more papers by this author
Srinivas Duvvuri MD

Srinivas Duvvuri MD

Cardiovascular Institute, Mount Sinai Medical Center, New York City

Search for more papers by this author
John A. Ambrose MD

John A. Ambrose MD

Cardiovascular Institute, Mount Sinai Medical Center, New York City

Search for more papers by this author
Samin K. Sharma MD

Samin K. Sharma MD

Cardiovascular Institute, Mount Sinai Medical Center, New York City

Search for more papers by this author
First published: October 1996
Citations: 11

Abstract

Pseudoaneurysm (PA) formation is a well-documented complication of femoral arterial puncture in patients undergoing percutaneous cardiac procedures. Besides surgical repair, there has been success in obliterating the PAS by Duplex ultrasound guided compression (mostly those <4.0 cm). We analyzed the use of prolonged femoral compression using a pneumatic compression system (FemoStop by USCI) in 10 patients who developed femoral PAS following an interventional cardiac procedure. All PAS were diagnosed by ultrasound and had unsuccessful duplex-guided compression. The size of the PA ranged from 2.8–4.0 cm in diameter. All patients had the FemoStop system placed over the PA with continuous pressure for 12–18 hr. PA obliteration was successful in 90% of cases as confirmed by ultrasound. The only complication observed was skin abrasion in two patients. Our results indicate that the FemoStop system Is a simple and effective technique for treatment of femoral artery PAS.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.